Analytical Data
-
Gene name
Q360QC
- Application
-
Alternative Names
Q360QC；
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P03023
-
Expression Region
1-360aa
-
AA Sequence
MKPVTLYDVAEYAGVSYQTVSRVVNQASHVSAKTREKVEAAMAELNYIPNRVAQQLAGKQSLLIGVATSSLALHAPSQIVAAIKSRADQLGASVVVSMVERSGVEACKAAVHNLLAQRVSGLIINYPLDDQDAIAVEAACTNVPALFLDVSDQTPINSIIFSHEDGTRLGVEHLVALGHQQIALLAGPLSSVSARLRLAGWHKYLTRNQIQPIAEREGDWSAMSGFQQTMQMLNEGIVPTAMLVANDQMALGAMRAITESGLRVGADISVVGYDDTEDSSCYIPPLTTIKQDFRLLGQTSVDRLLQLSQGQAVKGNQLLPVSLVKRKTTLAPNTQTASPRALADSLMQLARQVSRLESGQC
-
Molecular Weight
44.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Q360QC is a recombinant protein that has garnered significant attention in the field of biotechnology and molecular biology due to its potential applications in therapeutic and diagnostic contexts. The research surrounding Q360QC stems from the increasing demand for high-purity proteins that can be utilized in various biotechnological processes, including the development of vaccines, monoclonal antibodies, and enzyme replacements. This protein is engineered to possess specific structural and functional properties, allowing for enhanced stability and activity in physiological conditions. Advances in recombinant DNA technology have enabled scientists to produce Q360QC in host cells, such as E. coli or mammalian cells, which leads to efficient production techniques and the ability to scale up manufacturing processes. Furthermore, studies on Q360QC focus on understanding its biochemical interactions, mechanisms of action, and potential therapeutic benefits, positioning it as a promising candidate for treating a variety of diseases, including cancers and genetic disorders. Ongoing research aims to optimize the expression systems and purification methods for Q360QC, ensuring that the final product meets the stringent quality standards required for clinical applications. As the relevance of personalized medicine grows, Q360QC serves as a critical tool in the arsenal of modern therapeutics, responding to the need for innovative solutions in patient care and disease management. The continuous exploration of its properties and applications reflects the dynamic nature of protein research and its role in advancing healthcare solutions.
